ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
stanjupiter
|
179 |
49K |
28 |
12/12/21 |
12/12/21 |
ASX - By Stock
|
179
|
49K
|
28
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
stanjupiter
|
179 |
49K |
15 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
179
|
49K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
stanjupiter
|
179 |
49K |
8 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
179
|
49K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
stanjupiter
|
179 |
49K |
35 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
179
|
49K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
stanjupiter
|
179 |
49K |
62 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
179
|
49K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
stanjupiter
|
11K |
3.5M |
25 |
12/09/21 |
12/09/21 |
ASX - By Stock
|
11K
|
3.5M
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
stanjupiter
|
1.0K |
424K |
17 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
1.0K
|
424K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
stanjupiter
|
1.0K |
424K |
40 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
1.0K
|
424K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stanjupiter
|
18K |
7.0M |
29 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
18K
|
7.0M
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
stanjupiter
|
344 |
101K |
10 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
344
|
101K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial 90-Day Survival Outcomes Presented at ISCT
|
|
stanjupiter
|
251 |
93K |
73 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
251
|
93K
|
73
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
10K |
3.0M |
23 |
27/06/21 |
27/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stanjupiter
|
18K |
7.0M |
37 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
18K
|
7.0M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
stanjupiter
|
300 |
87K |
14 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
300
|
87K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
stanjupiter
|
300 |
87K |
38 |
24/06/21 |
24/06/21 |
ASX - By Stock
|
300
|
87K
|
38
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
stanjupiter
|
300 |
87K |
65 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
300
|
87K
|
65
|
|
ASX - By Stock
|
MSB |
Re:
Alzheimer drug approved
|
|
stanjupiter
|
243 |
74K |
8 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
243
|
74K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Alzheimer drug approved
|
|
stanjupiter
|
243 |
74K |
12 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
243
|
74K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
32 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
469K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
4 |
07/06/21 |
07/06/21 |
ASX - By Stock
|
1.6K
|
469K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
71 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
1.6K
|
469K
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
26 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
8 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
36 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
19 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
13 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
30 |
16/05/21 |
16/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
stanjupiter
|
1.6K |
469K |
101 |
15/05/21 |
15/05/21 |
ASX - By Stock
|
1.6K
|
469K
|
101
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stanjupiter
|
18K |
7.0M |
17 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
18K
|
7.0M
|
17
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
10K |
3.0M |
39 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
39
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
10K |
3.0M |
78 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
78
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
29 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
533
|
195K
|
29
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
13 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
533
|
195K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Reduces Biomarkers for Mortality in SR-aGVHD
|
|
stanjupiter
|
139 |
73K |
30 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
139
|
73K
|
30
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
stanjupiter
|
36 |
12K |
6 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
36
|
12K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
stanjupiter
|
36 |
12K |
11 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
36
|
12K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
stanjupiter
|
36 |
12K |
17 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
36
|
12K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
stanjupiter
|
36 |
12K |
43 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
36
|
12K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
How many red flags do you need?
|
|
stanjupiter
|
36 |
12K |
25 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
36
|
12K
|
25
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
5 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
533
|
195K
|
5
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
5 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
533
|
195K
|
5
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
3 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
533
|
195K
|
3
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
14 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
533
|
195K
|
14
|
|
ASX - By Stock
|
MSB Iron Ore |
Re:
AFR reports that the co to be sued for its promotional announcements.
|
|
stanjupiter
|
533 |
195K |
52 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
533
|
195K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
522K |
59 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
1.0K
|
522K
|
59
|
|
ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
stanjupiter
|
14K |
7.3M |
4 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
14K
|
7.3M
|
4
|
|
ASX - By Stock
|
A2M |
Re:
A2accumulate Mark06
|
|
stanjupiter
|
94 |
43K |
3 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
94
|
43K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
522K |
55 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
522K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
522K |
79 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
522K
|
79
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
10K |
3.0M |
2 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|